UA83680U - Method for complex rehabilitation of patients with neurodermatitis - Google Patents
Method for complex rehabilitation of patients with neurodermatitisInfo
- Publication number
- UA83680U UA83680U UAU201303460U UAU201303460U UA83680U UA 83680 U UA83680 U UA 83680U UA U201303460 U UAU201303460 U UA U201303460U UA U201303460 U UAU201303460 U UA U201303460U UA 83680 U UA83680 U UA 83680U
- Authority
- UA
- Ukraine
- Prior art keywords
- neurodermatitis
- patients
- complex rehabilitation
- complex
- rehabilitation
- Prior art date
Links
- 201000009053 Neurodermatitis Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- -1 adaptogens Substances 0.000 abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 229940009098 aspartate Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 238000002647 laser therapy Methods 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 229940125723 sedative agent Drugs 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000000021 stimulant Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A method for complex treatment of neurodermatitis patients comprising the administering of antihistamines, antioxidants, bio-stimulants, adaptogens, sedatives agents. In this case, Tivortin aspartate, Decamevit, folic acid, sodium chloride mineral water "Bronnichanka" and laser therapy are introduced in addition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201303460U UA83680U (en) | 2013-03-21 | 2013-03-21 | Method for complex rehabilitation of patients with neurodermatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201303460U UA83680U (en) | 2013-03-21 | 2013-03-21 | Method for complex rehabilitation of patients with neurodermatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA83680U true UA83680U (en) | 2013-09-25 |
Family
ID=52279020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201303460U UA83680U (en) | 2013-03-21 | 2013-03-21 | Method for complex rehabilitation of patients with neurodermatitis |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA83680U (en) |
-
2013
- 2013-03-21 UA UAU201303460U patent/UA83680U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017502154A1 (en) | Methods for conditioning patients for t cell therapy | |
| CY1124135T1 (en) | DOSAGE FORMS FOR THE TREATMENT OF ROMRE'S DISEASE | |
| MX2017014338A (en) | Targeted selection of patients for treatment with cortistatin derivatives. | |
| PH12014502738A1 (en) | High-xten fusion protein and its use in the treatment of growth hormone deficiency | |
| MX2021000071A (en) | Use of pridopidine to improve cognitive function and for treating alzheimer's disease. | |
| IN2014DN11099A (en) | ||
| BR112015026006A2 (en) | methods for treating cancer with the use of tor kinase inhibitor combination therapy | |
| MX2016000173A (en) | Systems and methods for tracking and presenting tinnitus therapy data. | |
| MX2013000319A (en) | Treatment of cognitive disorders. | |
| MX2015012322A (en) | Use of levocetirizine and montelukast in the treatment of autoimmune disorders. | |
| MX2015016527A (en) | Proton-binding polymers for oral administration. | |
| IN2015DN03219A (en) | ||
| AR089862A1 (en) | USE OF LAQUINIMOD FOR THE TREATMENT OF PATIENTS WITH CROHN'S DISEASE IN THOSE WHO FAILS AN ANTI-FACTOR THUMOR NECROSIS THERAPY a (ANTI-TNFa) FIRST LINE | |
| MX2015011905A (en) | Use of levocetirizine and montelukast in the treatment of vasculitis. | |
| MX2021004558A (en) | Proton-binding polymers for oral administration. | |
| MX2018010223A (en) | Combination therapy for treatment of ovarian cancer. | |
| PH12015502616A1 (en) | Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer | |
| ZA201708686B (en) | Nanoparticles for use as a therapeutic vaccine | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| MX349767B (en) | Diethyl- [6- (4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl) - naphthalen-2-yl-methyl] -ammonium chloride for use in the treatment of muscular dystrophy. | |
| UA83680U (en) | Method for complex rehabilitation of patients with neurodermatitis | |
| MX2017013668A (en) | Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer. | |
| TN2014000418A1 (en) | Methods for treating cancer using pi3k inhibitor and mek inhibitor | |
| UA112357C2 (en) | METHOD OF INDIVIDUAL TARGET THERAPY OF VITAMIN D DEFICIENCY IN PATIENTS WITH BONE AND MUSCLE DISEASES |